Arax Advisory Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Arax Advisory Partners's CDNA Position: Q2 2026 in Review
Arax Advisory Partners increased its CareDx (CDNA) stake by 202% in Q2 2026, buying an estimated $21.3K and bringing the position to 1,465 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.
Arax Advisory Partners first reported a position in CDNA in Q2 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Arax Advisory Partners held 1,465 shares of CareDx worth $41.8K as of Q2 2026.
- Arax Advisory Partners bought 980 CareDx shares in Q2 2026, an estimated $21.3K.
- CareDx made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3419 holding.
- Arax Advisory Partners first reported a position in CareDx in Q2 2024 and has held it in 7 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.